Sign in

CIK 0001662579

  • Non-accelerated filer
  • Smaller reporting company

C4 Therapeutics, Inc.

Sign in to watch
Ticker
CCCC
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
475617627
Phone
+1 617-231-0700
Business address
490 ARSENAL WAY, SUITE 120, WATERTOWN, MA, 02472
  1. 4/A Shares withheld for taxes Chief Medical Officer gave up 1,102 shares (to pay taxes)
  2. 4/A Shares withheld for taxes Chief Business Officer gave up 1,102 shares (to pay taxes)
  3. 4 Option exercise Chief Legal Officer acquired 3,750 shares (option exercise)
  4. 4 Option exercise Chief Medical Officer acquired 3,750 shares (option exercise)
  5. 4 Option exercise Chief People Officer acquired 3,750 shares (option exercise)
  6. 4 Option exercise Chief Scientific Officer acquired 3,750 shares (option exercise)
  7. 4 Option exercise Chief Financial Officer acquired 3,750 shares (option exercise)
  8. 4 Option exercise Chief Business Officer acquired 3,750 shares (option exercise)
  9. 4 Option exercise President & CEO acquired 12,500 shares (option exercise)
  10. 4 Option exercise Chief Scientific Officer acquired 28,084 shares (option exercise)
  11. 4 Open-market buy President & CEO bought 10,000 shares at $8.40 ($84,000)
  12. 4 Grant or award Director acquired 379 shares (grant or award)
  13. 4 Grant or award Director acquired 388 shares (grant or award)
  14. 4 Grant or award Director acquired 341 shares (grant or award)
  15. 4 Derivatives Options or other derivatives
  16. 3 Insider Initial Statement of Ownership
  17. 3 Insider Initial Statement of Ownership
  18. 3 Insider Initial Statement of Ownership
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 10 of 15 · 296 filings